Cell kinetic measurements in prostate cancer

International Journal of Radiation Oncology Biology Physics

Volumn 37, Issue 5, 1997, Pages 1067-1070

  Haustermans, Karin M G ^a   Hofland, Ingrid ^b   Van Poppel, Hein ^a   Oyen, Raymond ^a   De Voorde, Wim Van ^a   Begg, Adrian C ^b   Fowler, Jack F ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Cell kinetics; Prostate cancer; Radiation

Indexed keywords

IDOXURIDINE;

ARTICLE; CANCER RADIOTHERAPY; CELL KINETICS; CELL PROLIFERATION; CLINICAL ARTICLE; DNA SYNTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LABELING INDEX; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; TUMOR CELL;

EID: 0030976825     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(96)00579-2     Document Type: Article

References (20)

1. Amdur, R. J.; Parsons, J. T.; Fitzgerald, L. T.; Million, R. R. The effect of overall treatment time on local control in patients with adenocarcinoma of the prostate treated with radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 19:1377-1381; 1990.
2. Begg, A. C.; McNally, N. J.; Shrieve, D. C.; Kaercher, H. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry 6:620-626; 1985.
3. Carroll, P. R.; Waldman, F. M.; Rosenau, W.; Cohen, M. B.; Vapnek, J. M.; Fong, P.; Narayan, P.; Mayall, B. H. Cell proliferation in prostatic adenocarcinoma: In vitro measurement by 5-bromodeoxyuridine incorporation and proliferating cell nuclear antigen expression. J. Urol. 149:403-407; 1993.
4. D'Amico, A. V.; Hanks, G. E. Linear regressive analysis using prostate-specific antigen doubling time for predicting tumor biology and clinical outcome in prostate cancer. Cancer 72:2638-2643; 1993.
5. Forman, J. D.; Duclos, M.; Shamsa, F.; Porter, A. T.; Orton, C. Hyperfractionated conformal radiotherapy in locally advanced prostate cancer: results of a dose escalation study. Int. J. Radiat. Oncol. Biol. Phys. 34:655-662; 1996.
6. Forman, J. D.; Orton, C.; Ezzell, G.; Porter, A. T. Preliminary results of a hyperfractionated dose escalation study for locally advanced adenocarcinoma of the prostate. Radiother. Oncol. 27:203-208; 1993.
7. Fowler, J. F. The effect of overall treatment time in radiotherapy for localized prostate carcinoma. 21:1097-1098; 1991.
8. Fowler, J. F. Brief summary of radiobiological principles in fractionated radiotherapy. Semin. Radiat. Oncol. 2:16-21; 1992.
9. Fowler, J. F.; Ritter, M. A. A rationale for fractionation for slowly proliferating tumors such as prostatic carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 32:521-529; 1995.
10. Hanks, G. E.; Hanlon, A. L.; Lee, W. R.; Slivjak, A.; Schultheiss, T. E. Pretreatment prostate-specific antigen doubling times: Clinical utility of this predictor of prostate cancer behavior. Int. J. Radiat. Oncol. Biol. Phys. 34:549-553; 1996.
11. Hanks, G. E.; Krall, J. M.; Hanlon, A. L.; Asbell, S. O.; Pipelich, M. V.; Owen, J. B. Patterns of care and RTOG studies in prostate cancer: Long-term survival, hazard rate observations, and possibilities of cure. Int. J. Radiat. Oncol. Biol. Phys. 28:39-45; 1994.
12. Lai, P. P.; Perez, C. A.; Shapiro, S. J.; Lockett, M. A. Carcinoma of the prostate Stage B and C: Lack of influence of duration of radiotherapy on tumor control and treatment morbidity. Int. J. Radiat. Oncol. Biol. Phys. 19:561-568; 1990.
13. Leibel, S. A.; Heimann, R.; Kutcher, G.; Zelefsky, M. J.; Burman, C. M.; Melian, E.; Ozarem; J. P.; Mohan, R.; LoSasso, T. J.; Lo, Y. C.; Wiseberg, J. A.; Chapman, D. S.; Ling, C. C.; Fuks, Z. Three-dimensional conformal radiation therapy in locally advanced carcinoma of the prostate: Preliminary results of a Phase I dose-escalation study. Int. J. Radiat. Oncol. Biol. Phys. 28:55-65; 1994.
14. Meyer, S. J.; Sufrin, G.; Martin, S. A. Proliferative activity of benign human prostate, prostatic adenocarcinoma and seminal vesicle evaluated by thymidine labelling. J. Urol. 128:1353-1358; 1982.
15. Nemoto, R.; Katsunori, U.; Shimazu, T.; Haltori, K.; Koiso, K.; Harada, M. Immunocytochemical demonstration of S phase cells by anti-bromodeoxyuridine monoclonal antibody in human prostate adenocarcinoma. J. Urol. 141:337-340; 1989.
16. Rew, D. A.; Thomas, D. J.; Coptcoat, M.; Wilson, G. D. Measurement of in vivo urological tumour cell kinetics using multiparameter flow cytometry. Br. J. Urol. 68:44-48; 1991.
17. Schmid, H. P.; McNeal, J. E.; Stamey, T. A. Observations on the doubling time of prostate cancer. The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume. Cancer 71:2031-2040; 1993.
18. Scrivner, D. L.; Meyer, J. S.; Rujanavech, N.; Fathman, A.; Scully, T. Cell kinetics by bromodeoxyuridine labeling and deoxyribonucleic acid ploidy in prostatic carcinoma needle biopsies. J. Urol. 146:1034-1039; 1991.
19. Steel, G. G. Growth kinetics of tumors. Oxford: Clarendon Press; 1977.
20. Withers, H. D.; Thames, H. D.; Peters, L. J. Differences in the fractionation response of acutely and late-responding tissues. In: Kaercher, K. H.; Kogelnik, H. D.; Reinartz, G., eds. Progress in radio-oncology, vol. 2. New York: Raven Press; 1982:287-296.